Chimeric Antigen Receptors (car) - Pharma

Relevant Publications

Emerging Novel Combined CAR-NK Cell Therapies in Cancer Treatment: Finding a Dancing Partner.

Issue Release: 2025

Exploring CAR-macrophages in non-tumor diseases: Therapeutic potential beyond cancer.

Issue Release: 2025

CAR-T Cells in Acute Myeloid Leukemia: Where Do We Stand?

Issue Release: 2024

Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function.

Issue Release: 2024

Recent advances in immunotherapy in cancer treatment.

Issue Release: 2024

Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation.

Issue Release: 2024

Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

Issue Release: 2024

Engineered CD47 protects T cells for enhanced antitumour immunity.

Issue Release: 2024

Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors.

Issue Release: 2024

Autoimmune CD8+ T cells in type 1 diabetes: from single-cell RNA sequencing to T-cell receptor redirection.

Issue Release: 2024

Sensitive bispecific chimeric T cell receptors for cancer therapy.

Issue Release: 2024

Chimeric antigen receptor-natural killer cell therapy: current advancements and strategies to overcome challenges.

Issue Release: 2024

Library-based single-cell analysis of CAR signaling reveals drivers of persistence.

Issue Release: 2024

Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy.

Issue Release: 2024

The potential of γδ CAR and TRuC T cells: An unearthed treasure.

Issue Release: 2024

CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges.

Issue Release: 2024

CD19-chimeric antigen receptor-invariant natural killer T cells transactivate NK cells and reduce alloreactivity.

Issue Release: 2024

Engineering Transcriptional Regulation for Cell-Based Therapies.

Issue Release: 2024

Multimodal probing of T-cell recognition with hexapod heterostructures.

Issue Release: 2024

Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances.

Issue Release: 2024

What is Medication Management?

What Should Be Included in Patient Education Materials?

Why is Generic Competition Important?

How Do Collaborative Care Models Work?

What are the Key Challenges?

What is an Abbreviated New Drug Application (ANDA)?

How Are Participants Protected?

What is Pharma?

What are the Challenges in Implementing Collaborative Care Models?

How Can Cellular Stress Be Measured?

Partnered Content Networks

Relevant Topics